# Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab

> **NCT01814501** · PHASE2 · COMPLETED · sponsor: **John Hays** · enrollment: 16 (actual)

## Conditions studied

- Mucinous Adenocarcinoma of the Colon
- Mucinous Adenocarcinoma of the Rectum
- Recurrent Colon Cancer
- Recurrent Rectal Cancer
- Signet Ring Adenocarcinoma of the Colon
- Signet Ring Adenocarcinoma of the Rectum
- Stage IV Colon Cancer
- Stage IV Rectal Cancer

## Interventions

- **BIOLOGICAL:** panitumumab
- **DRUG:** irinotecan hydrochloride
- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium

## Key facts

- **NCT ID:** NCT01814501
- **Lead sponsor:** John Hays
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-01
- **Primary completion:** 2018-08-06
- **Final completion:** 2018-08-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01814501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01814501, "Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01814501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*